Simlandi became the 10th FDA-approved Humira biosimilar in February 2024. It's the first high-concentration and citrate-free interchangeable Humira biosimilar.

A Review of Newly Available Humira Biosimilars for Pharmacists. Adalimumab (Humira, AbbVie) has become one of the world's best-selling drugs for treating ...

Nine adalimumab biosimilars are hitting the market this year, beginning with Amjevita in January. The others — Abrilada, Cyltezo, Hadlima, Hulio, Hyrimoz, ...

18 июл. 2023 г. · Three of these biosimilars — Hadlima, Hyrimoz, and Yuflyma — are available in high concentration formulations. This high concentration ...

19 окт. 2023 г. · This article explores the characteristics of various adalimumab biosimilars to help clinicians navigate the various options available across Europe and the USA.

4 июл. 2023 г. · Eli Lilly and Novo Nordisk, they're in the lead right now, for sure. These products had a major impact on the market capitalization of both ...

24 мар. 2023 г. · Amgen's (US) Amjevita (adalimumab) is the first Humira biosimilar, launched in February 2023, and seven other FDA-approved biosimilars are ...

30 июл. 2024 г. · The first adalimumab biosimilar, Amgen's Amjevita, was approved in the US in 2016 [2], and since then, eight more have been approved. However, ...

22 авг. 2023 г. · Amgen launched the first Humira biosimilar, called Amjevita, earlier this year. The list price for one version of Amjevita is just 5% lower ...

5 июл. 2023 г. · Cyltezo®, first and only FDA-approved Interchangeable biosimilar to Humira®, now commercially available in the U.S. News release. Boehringer ...